Gonadal hormone modulation of ∆9-tetrahydrocannabinol-induced antinociception and metabolism in female versus male rats.
The gonadal hormones testosterone (T) in adult males and estradiol (E2) in adult females have been reported to modulate behavioral effects of ∆9-tetrahydrocannabinol (THC). This study determined whether activational effects of T and E2 are sex-specific, and whether hormones modulate production of the active metabolite 11-hydroxy-THC (11-OH-THC) and the inactive metabolite 11-nor-9-carboxy-THC (THC-COOH). Adult male and female rats were gonadectomized (GDX) and treated with nothing (0), T (10-mm Silastic capsule/100g body weight), or E2 (1-mm Silastic capsule/rat). Three weeks later, saline or the cytochrome P450 inhibitor proadifen (25mg/kg; to block THC metabolism and boost THC's effects) was injected i.p.; 1h later, vehicle or THC (3mg/kg females, 5mg/kg males) was injected i.p., and rats were tested for antinociceptive and motoric effects 15-240min post-injection. T did not consistently alter THC-induced antinociception in males, but decreased it in females (tail withdrawal test). Conversely, T decreased THC-induced catalepsy in males, but had no effect in females. E2 did not alter THC-induced antinociception in females, but enhanced it in males. The discrepant effects of T and E2 on males' and females' behavioral responses to THC suggests that sexual differentiation of THC sensitivity is not simply due to activational effects of hormones, but also occurs via organizational hormone or sex chromosome effects. Analysis of serum showed that proadifen increased THC levels, E2 increased 11-OH-THC in GDX males, and T decreased 11-OH-THC (and to a lesser extent, THC) in GDX females. Thus, hormone modulation of THC's behavioral effects is caused in part by hormone modulation of THC oxidation to its active metabolite. However, the fact that hormone modulation of metabolism did not alter THC sensitivity similarly on all behavioral measures within each sex suggests that other mechanisms also play a role in gonadal hormone modulation of THC sensitivity in adult rats.
Department of Psychology, Washington State University, Pullman, WA, United States. Electronic address: craft@wsu.edu.
R M
RM
Craft
Department of Psychology, Washington State University, Pullman, WA, United States.
A E
AE
Haas
RTI International, Durham, NC, United States.
J L
JL
Wiley
Department of Chemistry, Washington State University, Pullman, WA, United States.
Z
Z
Yu
Department of Chemistry, Washington State University, Pullman, WA, United States.
B H
BH
Clowers
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D002375:Catalepsy / Q000139:chemically induced / Q000517:prevention & control; D013759:Dronabinol / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors* / Q000097:blood / Q000494:pharmacology*; D004347:Drug Interactions; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D008297:Male; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D012727:Sex Characteristics; D013739:Testosterone / Q000494:pharmacology*
D000700:Analgesics; D013739:Testosterone; D004958:Estradiol; D013759:Dronabinol; D011335:Proadifen
Analgesia; Cannabinoids; Estrogen; Gender; Sex differences; Testosterone
Drug Metab Dispos. 1990 Nov-Dec;18(6):943-8
1981541
Pain. 2003 Jun;103(3):285-302
12791435
Eur J Pharmacol. 2001 Oct 26;430(1):41-7
11698061
Brain Res Dev Brain Res. 2002 Jun 30;136(2):85-92
12101025
Drug Metab Dispos. 1992 Jan-Feb;20(1):79-83
1347001
Pain. 2012 Nov;153(11):2283-91
22940464
Endocrinology. 2005 Apr;146(4):1650-73
15618360
Eur J Pharmacol. 2008 Jan 6;578(1):37-42
17905227
Arch Biochem Biophys. 1986 Aug 1;248(2):658-76
2427030
Science. 1972 Jul 7;177(4043):62-4
5041775
Pharmacol Biochem Behav. 2015 Jun;133:111-21
25863271
Life Sci. 2013 Mar 19;92(8-9):476-81
22728714
Curr Med Res Opin. 2008 Apr;24(4):1017-24
18302810
Psychopharmacology (Berl). 1979 Mar 28;61(3):281-5
156380
Pharmacol Rev. 1986 Mar;38(1):21-43
3012605
Life Sci. 1977 Jun 15;20(12):1993-2003
881943
Eur J Pharmacol. 2008 May 31;586(1-3):189-96
18371951
Toxicol Lett. 1992 Dec;64-65 Spec No:661-7
1471220
Pharmacol Biochem Behav. 2014 Sep;124:269-77
24951841
Behav Brain Res. 2004 Sep 23;154(1):77-83
15302113
Scand J Gastroenterol. 2008 Jan;43(1):66-72
18938775
J Pharmacol Exp Ther. 2012 Mar;340(3):787-800
22182934
Arch Biochem Biophys. 1992 Jul;296(1):286-95
1605637
J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):227S-234S
6271828
Behav Brain Res. 2011 Jan 1;216(1):200-6
20692296
Int J Biochem Cell Biol. 1995 Aug;27(8):741-6
7584607
Clin Pharmacol Ther. 1983 Sep;34(3):352-63
6309462
Neurosci Lett. 2014 Jul 25;576:51-5
24909619
Clin Pharmacokinet. 2007;46(2):133-57
17253885
Addict Biol. 1999 Jul;4(3):283-301
20575795
Ther Drug Monit. 2005 Dec;27(6):799-810
16306858
Pain. 2013 Sep;154(9):1709-17
23707295
Annu Rev Pharmacol Toxicol. 2004;44:499-523
14744256
Neuropsychopharmacology. 2013 Sep;38(10):1984-92
23609132
Life Sci. 2007 Mar 20;80(15):1415-9
17303175
Res Commun Chem Pathol Pharmacol. 1974 Jun;8(2):389-92
4851722
Biochem Pharmacol. 1991 Apr 15;41(8):1187-94
1848985